MedTrace Logo

Study for the Assessment of the Quality of Echocardiographic Clips.

NCT05090748 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 240

Last updated 2022-12-07

No results posted yet for this study

Summary

This study main objective is to evaluate the safety and efficacy of the UltraSight AI Guidance software. The investigational product is a software that guides the user to capture a high quality ultrasound image. The study will include healthcare professionals, not specialized in echocardiography, who will perform echocardiography by using UltraSight AI Guidance software, on subjects in the medical centers cardiac units.

Conditions

  • Cardiac Disease

Interventions

DEVICE

Echocardiographic.

Echocardiographic test.

Sponsors & Collaborators

  • UltraSight

    lead INDUSTRY

Principal Investigators

  • Roberto Lang, MD · U of Chicago

  • Federico Asch, MD · Medstar Health Research Institute

  • Praveen Mehrotra, MD · Thomas Jefferson University

  • Bijoy Khandheria, MD · Aurora Saint Luke Medical Center

  • Robert Klampfner, MD · Sheba Medical Center

  • Danny Spigelstein, MD · UltraSight

Eligibility

Min Age
18 Years
Max Age
120 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-05-15
Primary Completion
2022-08-05
Completion
2022-08-31

Countries

  • United States
  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05090748 on ClinicalTrials.gov